Clorox (CLX) Tops Q1 EPS by 18c, Confirms Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/5/2026
- Wall St slides as chip stocks fall, jobs data fuels hawkish Fed fears
- U.S. economy adds 172,000 jobs in May, topping expectations
- Citi warns global stock markets are the frothiest since 2008
- JPMorgan upgrades Tesla, sets new price target on robotaxi and Optimus potential
- Fed risks fueling a stock bubble by overlooking AI-driven inflation: BCA
- Broadcom results, guidance beat on soaring AI chip sales; stock slips after hours
- Wells Fargo Upgrades Oscar Health Inc (OSCR) to Equal Weight 'on Greater Confidence in Exchange Market Trajectory in 2026'
- Dow claims record closing high, S&P 500 advances; chip selloff weighs on Nasdaq
- Wall St slides as chip stocks fall, jobs data fuels hawkish Fed fears
- LCI Industries names interim CEO as Jason Lippert retires
Clorox Reports Q1 Fiscal Year 2022 Results, Confirms Outlook
November 1, 2021 4:10 PM EDTOAKLAND, Calif., Nov. 1, 2021 /PRNewswire/ --Â The Clorox Company (NYSE: CLX) today reported results for the first quarter of fiscal year 2022, which ended on Sept. 30, 2021.
First-Quarter Fiscal 2022 Summary
Following is a summary of key first-quarter results. All comparisons are with the first quarter of fiscal year 2021 unless otherwise stated.
Net sales declined 6% to $1.8 billion in comparison to a 27% increase in the year-ago quarter, or an increase of 21% on a two-year stack basis. The decline in net sales reflects a 2-point decline in volume, 3 points of... More